Srovnání testů vazebné aktivity na destičkový faktor von Willebrandova: ELISA překrývá typ 2B se ztrátou multimerů HMW 

Background: Plenty of new assays with completely different measuring ideas are out there to measure VWF GPIb-binding exercise, however little is understood about how these assays would possibly behave otherwise for subtypes of VWD.

Targets: The COMPASS-VWF examine was designed to check all out there VWF GPIb-binding exercise assays for von Willebrand issue. We particularly looked for specific assay conduct variations. Sufferers/Strategies To kind out random variations from systematic assay conduct deviations, all assays had been carried out in several laboratories on the identical samples in a blinded trend. Samples from 53 regular controls and 42 well-characterized VWD sufferers had been re-analysed on this examine to dissect assay-specific discrepancies.

Outcomes: No assay conduct variations had been discovered for 53 regular controls. For VWD sufferers, we discovered the next systematic assay conduct patterns: (i) All ELISA assays for VWF:GPIbR in addition to VWF:GPIbM are insensitive to detect the low VWF exercise of VWD kind 2B sufferers with lack of HMW multimers. (ii) VWF:Ab assay experiences larger exercise for the p.V1665E mutation than all different assays, and (iii) all ristocetin-based assays (together with VWF:RCo utilizing mounted platelets) however the AcuStar assay report discrepantly low VWF exercise for the p.P1467S polymorphism. No systematic assay-specific distinction was noticed for both the particle agglutination VWF:GPIbM assay, or the AcuStar assay utilizing magnetic beads.

Conclusions: Completely different assay ideas could result in discrepant outcomes for sure VWD sorts or mutations. Subsequently, a extra intensive examine for a lot of sufferers is required to raised characterise the incidence and relevance of such assay particular variations.

Take a look at ELISA professional studium interakcí rhinoviru a receptoru mezi významnými a menšími skupinami 

Rhinovirus (RV) infections are a significant reason for recurrent frequent colds and set off extreme exacerbations of power respiratory ailments. Main challenges for the event of vaccines for RV embrace the virus occurring within the type of roughly 160 completely different serotypes, utilizing completely different receptors, and the necessity for preclinical fashions for the screening of vaccine candidates and antiviral compounds. We report the institution and characterization of an ELISA-based assay for learning main and minor group RV-receptor interactions. This assay is predicated on the interplay of purified virus with plate-bound human receptor proteins, intercellular adhesion molecule 1 (ICAM-1), and low density lipoprotein receptor (LDLR). Utilizing RV strain-specific antibodies, we display the particular binding of a panel of main and minor RV group sorts together with RV-A and RV-B strains to ICAM-1 and LDLR, respectively.

We present that the RV-receptor interplay may be blocked with receptor-specific antibodies in addition to with soluble receptors and neutralizing RV-specific antibodies. The assay is extra delicate than a cell culture-based virus neutralization take a look at. The ELISA assay will due to this fact be helpful for the preclinical analysis for preventive and therapeutic methods concentrating on the RV-receptor interplay, corresponding to vaccines, antibodies, and anti-viral compounds.

QuantiFERON-TB Gold Plus: Vysoká kvalitativní a kvantitativní shoda mezi testy ELISA a CLIA 

QuantiFERON -TB Gold plus (QFT-plus) represents the most recent era of interferon-gamma launch assays (IGRAs), eliciting a response from CD8 T- cells along with CD4-T cells, with the goal to enhance detection of latent M.tuberculosis an infection (LTBI) with respect to its predecessor QuantiFERON-TB Gold In-Tube (QFT-GIT), even when no important variations have been proven between the 2 exams (1, 2).….

Jednoduchý a vysoce výkonný neutralizační take a look at na bázi ELISA professional stanovení antiflavivirových neutralizačních protilátek 

Mosquito-borne flavivirus infections, together with dengue virus and Zika virus, are main public well being threats globally. Whereas the plaque discount neutralization take a look at (PRNT) is taken into account the gold commonplace for figuring out neutralizing antibody ranges to flaviviruses, the assay is time-consuming and laborious. This examine, due to this fact, aimed to develop an enzyme-linked immunosorbent assay (ELISA)-based microneutralization take a look at (EMNT) for the detection of neutralizing antibodies to mosquito-borne flaviviruses. The inhibition of viral development attributable to neutralizing antibodies was decided colorimetrically through the use of EMNT. Given the significance of Fcγ-receptors (FcγR) in antibody-mediated neutralization and antibody-dependent enhancement (ADE) of flavivirus an infection, non-FcγR and FcγR-expressing cell strains had been used within the EMNT to permit the detection of the sum of neutralizing and immune-enhancing antibody exercise because the neutralizing titer.

Utilizing anti-flavivirus monoclonal antibodies and medical samples, the utility of EMNT was evaluated by evaluating the end-point titers of the EMNT and the PRNT. The correlation between EMNT and PRNT titers was robust, indicating that EMNT was sturdy and reproducible. The brand new EMNT assay combines the organic useful evaluation of virus neutralization exercise and the technical benefits of ELISA and, is easy, dependable, sensible, and may very well be automated for high-throughput implementation in flavivirus surveillance research and vaccine trials.

Vyhodnocení testu EUROIMMUN Anti-SARS-CoV-2 ELISA professional detekci protilátek IgA a IgG 

Because the Coronavirus 2019 (COVID-19) pandemic evolves, the event of immunoassays to assist decide publicity and doubtlessly predict immunity has turn into a urgent precedence. On this report we current the efficiency of the EUROIMMUN enzyme-linked immunosorbent assay (ELISA) for semi-quantitative detection of IgA and IgG antibodies in serum and plasma samples utilizing recombinant S1 area of the SARS-CoV-2 spike protein as antigen. Specimens from sufferers, with and with out COVID-19 an infection, had been examined on the College of Chicago Medical Microbiology and Immunology Laboratory. Of 86 samples from SARS-CoV-2 PCR-negative sufferers, together with 28 samples optimistic for frequent human coronavirus strains, 76 examined damaging and 10 examined optimistic for IgA (88.4% settlement, 95% CI: 79.9-93.6) whereas 84 examined damaging and a pair of examined optimistic for IgG (97.7% settlement, 95% CI: 91.9-99.6). Of 82 samples from SARS-CoV-2 PCR-positive sufferers, 14 examined damaging and 68 examined optimistic for IgA (82.9% settlement, 95% CI: 73.4-89.5) whereas 27 examined damaging and 55 examined optimistic for IgG (67.1% settlement, 95% CI: 56.3-76.3).

Of samples collected ≥Four days after optimistic PCR, 38 of 42 (90.5% settlement, 95% CI: 77.9-96.2) had been optimistic for IgA, and 42 of 42 (100% settlement, 95% CI: 91.6-100) had been optimistic for IgG, respectively. The EUROIMMUN Anti-SARS-CoV-2 ELISA Assay demonstrated good sensitivity for detection of IgA and wonderful sensitivity for detection of IgG antibodies from samples collected ≥Four days, after COVID-19 prognosis by PCR. This assay demonstrated good specificity for IgA and wonderful specificity for IgG and demonstrated solely borderline cross response in 2 of the 28 samples from sufferers with frequent human coronaviruses an infection, sorts NL63 and OC43.